Signal Transduction and Targeted Therapy (Jan 2023)
Preclinical characterization and anti-SARS-CoV-2 efficacy of ATV014: an oral cyclohexanecarboxylate prodrug of 1′-CN-4-aza-7,9-dideazaadenosine C-nucleoside
Abstract
No abstracts available.
Signal Transduction and Targeted Therapy (Jan 2023)